US Pharma MarketingThe post Investigational CRISPR therapy succeeds in patient with drug-resistant E. Coli appeared first on Clinical Trials Arena.
Investigational CRISPR therapy succeeds in patient with drug-resistant E. Coli
The CRISPR therapy, SNIPR001, was administered to the patient who had developed E. Coli following a single-patient emergency IND. The post Investigational CRISPR therapy succeeds in patient with drug-resistant E. Coli appeared first on Clinical Trials Arena .
The CRISPR therapy, SNIPR001, was administered to the patient who had developed E. Coli following a single-patient emergency IND.
Source: Clinical Trials Arena